Kolexia
Bourgeois Vincent Gastro-entérologie
Bourgeois Vincent
Gastro-entérologie
Centre Hospitalier de Boulogne sur Mer
Boulogne-sur-Mer, France
66 Activités
224 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs des voies biliaires Tumeurs des canaux biliaires Adénocarcinome Cholangiocarcinome Carcinomes Métastase tumorale Tumeurs du foie Carcinome hépatocellulaire

Collaborateurs

Voir plus
El Hajbi Farid
El Hajbi Farid
Centre Oscar-Lambret, Lille, France
Huguenin Bruno
Huguenin Bruno
Cabinet libéral, Bapaume, France
Capelle-Monnot Claire
Capelle-Monnot Claire
Centre Hospitalier de Boulogne sur Mer, Boulogne-sur-Mer, France
Manfredi Sylvain
Manfredi Sylvain
Hôpital François Mitterrand, Dijon, France

Industries

Voir plus
A+A
42 collaboration(s)
Dernière en 2023
B3TSI
23 collaboration(s)
Dernière en 2023
Servier
15 collaboration(s)
Dernière en 2023
Genactis SAS
9 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
604P Overall and progression-free survival of patients with metastatic colorectal cancer: A real-world prospective, longitudinal cohort study on the continuum of care (PROMETCO)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1517P Patient-related outcomes (PROs) after early palliative care (PC) (EPC) compared with standard oncologic care (SOC) for patients (pts) with metastatic upper gastrointestinal cancers (mUGIC): Results of the randomised EPIC trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocol.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 mai 2023
G-CSF filgrastim biosimilar-Sandoz reduces the incidence of febrile neutropenia in patients receiving chemotherapy regimens with rest periods not exceeding 14 days: A French, multicenter, prospective, non-interventional study.
Cancer treatment and research communications   10 février 2023
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.
Cancer medicine   16 novembre 2022
390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
International journal of cancer   14 juillet 2022
Aflibercept-LV5FU2 as first-line treatment of non-resectable metastatic colorectal cancers: Results of the FOLFA randomized phase II trial.
2022 ASCO Annual Meeting I   02 juin 2022